113 related articles for article (PubMed ID: 34019325)
1. New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication.
Katsuki T; Yamaji K; Soga Y; Iida O; Fujihara M; Kawasaki D; Ando K
Catheter Cardiovasc Interv; 2021 Sep; 98(3):E395-E402. PubMed ID: 34019325
[TBL] [Abstract][Full Text] [Related]
2. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
[TBL] [Abstract][Full Text] [Related]
3. Inverse association of diabetes and dialysis with the severity of femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases.
Takahara M; Soga Y; Fujihara M; Kawasaki D; Kozuki A; Iida O
BMC Cardiovasc Disord; 2020 Dec; 20(1):514. PubMed ID: 33297956
[TBL] [Abstract][Full Text] [Related]
4. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T;
JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770
[TBL] [Abstract][Full Text] [Related]
5. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
6. Comparison of paclitaxel-coated balloon angioplasty with femoropopliteal bypass surgery in treating femoropopliteal lesions.
Kavala AA; Kuserli Y; Turkyilmaz S
Vascular; 2021 Apr; 29(2):260-269. PubMed ID: 32838692
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication.
Soga Y; Yokoi H; Kawasaki T; Nakashima H; Tsurugida M; Hikichi Y; Nobuyoshi M
J Am Coll Cardiol; 2009 Jan; 53(1):48-53. PubMed ID: 19118724
[TBL] [Abstract][Full Text] [Related]
8. Ten-year clinical outcomes for patients undergoing lower extremity endovascular interventions.
Katsuki T; Yamaji K; Hiramori S; Tomoi Y; Soga Y; Ando K
J Vasc Surg; 2020 Nov; 72(5):1626-1635.e3. PubMed ID: 32278575
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions.
Okuno S; Iida O; Iida T; Takahara M; Yamaoka T; Kitano I; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Mano T
Ann Vasc Surg; 2019 May; 57():137-143. PubMed ID: 30500627
[TBL] [Abstract][Full Text] [Related]
10. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
12. Effect of Target Lesion Revascularization on Restenosis Lesions of the Superficial Femoral Artery without Recurred Symptoms after Endovascular Therapy.
Utsunomiya M; Takahara M; Fujihara M; Shiraki T; Kozuki A; Fukunaga M; Tan M; Yoshioka R; Tomoi Y; Mori S; Iwasaki Y; Sasaki S; Nakamura M
J Atheroscler Thromb; 2021 Jun; 28(6):643-655. PubMed ID: 32908114
[TBL] [Abstract][Full Text] [Related]
13. Lower extremity computed tomography angiography can help predict technical success of endovascular revascularization in the superficial femoral and popliteal artery.
Itoga NK; Kim T; Sailer AM; Fleischmann D; Mell MW
J Vasc Surg; 2017 Sep; 66(3):835-843.e1. PubMed ID: 28502550
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
Zhou Y; Wang J; He H; Li Q; Li M; Li X; Shu C
Int J Cardiol; 2021 Nov; 343():122-130. PubMed ID: 34461162
[TBL] [Abstract][Full Text] [Related]
15. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
[TBL] [Abstract][Full Text] [Related]
16. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions.
Hiramori S; Soga Y; Iida O; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Ando K
J Vasc Surg; 2017 Jun; 65(6):1690-1697. PubMed ID: 28268108
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cilostazol Administration on Femoropopliteal In-Stent Restenosis.
Tomoi Y; Soga Y; Iida O; Fujihara M; Ando K
J Endovasc Ther; 2017 Oct; 24(5):640-646. PubMed ID: 28675951
[TBL] [Abstract][Full Text] [Related]
18. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
[No Abstract] [Full Text] [Related]
19. Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization.
Jeon-Slaughter H; Khalili H; Tsai S; Armstrong EJ; Shammas NW; Jawaid O; Lu H; Addo T; Gigliotti O; Abu-Fadel M; Banerjee S
J Invasive Cardiol; 2018 Oct; 30(10):373-379. PubMed ID: 30279293
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Unsupervised Exercise Therapy After Endovascular Treatment for an Iliac Occlusive Lesion.
Kobayashi T; Hamamoto M; Okazaki T; Tomota M; Fujiwara T; Honma T; Takahashi S
Vasc Endovascular Surg; 2023 May; 57(4):331-338. PubMed ID: 36525961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
